Selected research
Industry Research
Immunohistochemistry Industry Research Report 2026
Market perspective
The global Immunohistochemistry market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immunohistochemistry is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immunohistochemistry is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immunohistochemistry is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immunohistochemistry include Thermo Fisher Scientific Inc., PerkinElmer, Inc., Merck Millipore, F. Hoffmann-La Roche Ltd, Danaher, Cell Signaling Technology, Inc., BioSB, Agilent Technologies, Inc. and Abcam plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immunohistochemistry market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immunohistochemistry Market by Company
Thermo Fisher Scientific Inc.
PerkinElmer, Inc.
Merck Millipore
F. Hoffmann-La Roche Ltd
Danaher
Cell Signaling Technology, Inc.
BioSB
Agilent Technologies, Inc.
Abcam plc
Immunohistochemistry Segment by Type
Kits
Reagents
Equipment
Antibodies
Immunohistochemistry Segment by Application
Diagnostics
Drug Testing
Immunohistochemistry Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunohistochemistry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunohistochemistry and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunohistochemistry.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immunohistochemistry manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immunohistochemistry by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immunohistochemistry in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Kits
- Reagents
- Equipment
- Antibodies
Applications
- Diagnostics
- Drug Testing
Companies covered
- Thermo Fisher Scientific Inc.
- PerkinElmer, Inc.
- Merck Millipore
- F. Hoffmann-La Roche Ltd
- Danaher
- Cell Signaling Technology, Inc.
- BioSB
- Agilent Technologies, Inc.
- Abcam plc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immunohistochemistry Market Size (2021-2032)
- 2.2.2 Global Immunohistochemistry Sales (2021-2032)
- 2.2.3 Global Immunohistochemistry Market Average Price (2021-2032)
- 2.3 Immunohistochemistry by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Kits
- 2.3.3 Reagents
- 2.3.4 Equipment
- 2.3.5 Antibodies
- 2.4 Immunohistochemistry by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diagnostics
- 2.4.3 Drug Testing
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immunohistochemistry Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immunohistochemistry Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Immunohistochemistry Revenue of Manufacturers (2021-2026)
- 3.4 Global Immunohistochemistry Average Price by Manufacturers (2021-2026)
- 3.5 Global Immunohistochemistry Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immunohistochemistry, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immunohistochemistry, Product Type & Application
- 3.8 Global Manufacturers of Immunohistochemistry, Established Date
- 3.9 Global Immunohistochemistry Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific Inc.
- 4.1.1 Thermo Fisher Scientific Inc. Company Information
- 4.1.2 Thermo Fisher Scientific Inc. Business Overview
- 4.1.3 Thermo Fisher Scientific Inc. Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Inc. Immunohistochemistry Product Portfolio
- 4.1.5 Thermo Fisher Scientific Inc. Recent Developments
- 4.2 PerkinElmer, Inc.
- 4.2.1 PerkinElmer, Inc. Company Information
- 4.2.2 PerkinElmer, Inc. Business Overview
- 4.2.3 PerkinElmer, Inc. Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 PerkinElmer, Inc. Immunohistochemistry Product Portfolio
- 4.2.5 PerkinElmer, Inc. Recent Developments
- 4.3 Merck Millipore
- 4.3.1 Merck Millipore Company Information
- 4.3.2 Merck Millipore Business Overview
- 4.3.3 Merck Millipore Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Millipore Immunohistochemistry Product Portfolio
- 4.3.5 Merck Millipore Recent Developments
- 4.4 F. Hoffmann-La Roche Ltd
- 4.4.1 F. Hoffmann-La Roche Ltd Company Information
- 4.4.2 F. Hoffmann-La Roche Ltd Business Overview
- 4.4.3 F. Hoffmann-La Roche Ltd Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 F. Hoffmann-La Roche Ltd Immunohistochemistry Product Portfolio
- 4.4.5 F. Hoffmann-La Roche Ltd Recent Developments
- 4.5 Danaher
- 4.5.1 Danaher Company Information
- 4.5.2 Danaher Business Overview
- 4.5.3 Danaher Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Danaher Immunohistochemistry Product Portfolio
- 4.5.5 Danaher Recent Developments
- 4.6 Cell Signaling Technology, Inc.
- 4.6.1 Cell Signaling Technology, Inc. Company Information
- 4.6.2 Cell Signaling Technology, Inc. Business Overview
- 4.6.3 Cell Signaling Technology, Inc. Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cell Signaling Technology, Inc. Immunohistochemistry Product Portfolio
- 4.6.5 Cell Signaling Technology, Inc. Recent Developments
- 4.7 BioSB
- 4.7.1 BioSB Company Information
- 4.7.2 BioSB Business Overview
- 4.7.3 BioSB Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BioSB Immunohistochemistry Product Portfolio
- 4.7.5 BioSB Recent Developments
- 4.8 Agilent Technologies, Inc.
- 4.8.1 Agilent Technologies, Inc. Company Information
- 4.8.2 Agilent Technologies, Inc. Business Overview
- 4.8.3 Agilent Technologies, Inc. Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Agilent Technologies, Inc. Immunohistochemistry Product Portfolio
- 4.8.5 Agilent Technologies, Inc. Recent Developments
- 4.9 Abcam plc
- 4.9.1 Abcam plc Company Information
- 4.9.2 Abcam plc Business Overview
- 4.9.3 Abcam plc Immunohistochemistry Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Abcam plc Immunohistochemistry Product Portfolio
- 4.9.5 Abcam plc Recent Developments
5 Global Immunohistochemistry Market Scenario by Region
- 5.1 Global Immunohistochemistry Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immunohistochemistry Sales by Region: 2021-2032
- 5.2.1 Global Immunohistochemistry Sales by Region: 2021-2026
- 5.2.2 Global Immunohistochemistry Sales by Region: 2027-2032
- 5.3 Global Immunohistochemistry Revenue by Region: 2021-2032
- 5.3.1 Global Immunohistochemistry Revenue by Region: 2021-2026
- 5.3.2 Global Immunohistochemistry Revenue by Region: 2027-2032
- 5.4 North America Immunohistochemistry Market Facts & Figures by Country
- 5.4.1 North America Immunohistochemistry Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immunohistochemistry Sales by Country (2021-2032)
- 5.4.3 North America Immunohistochemistry Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immunohistochemistry Market Facts & Figures by Country
- 5.5.1 Europe Immunohistochemistry Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immunohistochemistry Sales by Country (2021-2032)
- 5.5.3 Europe Immunohistochemistry Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immunohistochemistry Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immunohistochemistry Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immunohistochemistry Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immunohistochemistry Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immunohistochemistry Market Facts & Figures by Country
- 5.7.1 South America Immunohistochemistry Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immunohistochemistry Sales by Country (2021-2032)
- 5.7.3 South America Immunohistochemistry Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Immunohistochemistry Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immunohistochemistry Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immunohistochemistry Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immunohistochemistry Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immunohistochemistry Sales by Type (2021-2032)
- 6.1.1 Global Immunohistochemistry Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Immunohistochemistry Sales Market Share by Type (2021-2032)
- 6.2 Global Immunohistochemistry Revenue by Type (2021-2032)
- 6.2.1 Global Immunohistochemistry Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immunohistochemistry Revenue Market Share by Type (2021-2032)
- 6.3 Global Immunohistochemistry Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immunohistochemistry Sales by Application (2021-2032)
- 7.1.1 Global Immunohistochemistry Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Immunohistochemistry Sales Market Share by Application (2021-2032)
- 7.2 Global Immunohistochemistry Revenue by Application (2021-2032)
- 7.2.1 Global Immunohistochemistry Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immunohistochemistry Revenue Market Share by Application (2021-2032)
- 7.3 Global Immunohistochemistry Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immunohistochemistry Value Chain Analysis
- 8.1.1 Immunohistochemistry Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immunohistochemistry Production Mode & Process
- 8.2 Immunohistochemistry Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immunohistochemistry Distributors
- 8.2.3 Immunohistochemistry Customers
9 Global Immunohistochemistry Analyzing Market Dynamics
- 9.1 Immunohistochemistry Industry Trends
- 9.2 Immunohistochemistry Industry Drivers
- 9.3 Immunohistochemistry Industry Opportunities and Challenges
- 9.4 Immunohistochemistry Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst